EZH2 and cancer: Next, because the GSEA analysis and transcriptome data of TAMR and ADR revealed EMT of the drug-resistant cells, we also investigated whether the EZH2-integrin α11 axis is the key regulator of EMT, which plays multiple roles in cancer progression including drug resistance, metastasis, and recurrence [45–47].